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A B S T R A C T
Recently, we identiﬁed a unique -2/-1 ribosomal frameshift mechanism in PRRSV, which yields two truncated
forms of nonstructural protein (nsp) 2 variants, nsp2TF and nsp2N. Here, in vitro expression of individual PRRSV
nsp2TF and nsp2N demonstrated their ability to suppress cellular innate immune responses in transfected cells.
Two recombinant viruses were further analyzed, in which either nsp2TF was C-terminally truncated (vKO1) or
expression of both nsp2TF and nsp2N was knocked out (vKO2). Host cellular mRNA proﬁling showed that a
panel of cellular immune genes, in particular those involved in innate immunity, was upregulated in cells in-
fected with vKO1 and vKO2. Compared to the wild-type virus, vKO1 and vKO2 expedited the IFN-α response and
increased NK cell cytotoxicity, and subsequently enhanced T cell immune responses in infected pigs. Our data
strongly implicate nsp2TF/nsp2N in arteriviral immune evasion and demonstrate that nsp2TF/nsp2N-deﬁcient
PRRSV is less capable of counteracting host innate immune responses.
1. Introduction
The innate immune response provides the ﬁrst line of defense
against intruding pathogens. It is essential for the initial control of in-
fection and allows time for launching an adequate adaptive immune
response. The type I interferon (IFN) system is a key component of the
innate immune response (Haller et al., 2006; Randall and Goodbourn,
2008). Initially, pathogen-associated molecular patterns, like double-
stranded RNA (dsRNA) in the case of RNA virus infection, are re-
cognized by host cell receptors to activate protein signaling cascades,
which results in the activation of transcription factors, including IRF3,
NF-κB, and ATF-2/c JUN. Their coordinated activation leads to the
formation of transcriptionally competent enhanceosomes in the cell
nucleus, which induce the expression of type I IFNs. After being se-
creted from infected cells, type I IFNs bind to receptors on the surface of
adjacent cells to activate the so-called JAK-STAT signaling pathway.
This induces the transcription of a range of interferon-stimulated genes
(ISGs), whose products function as eﬀector molecules in the host cell
response to viral infection (Raftery and Stevenson, 2017; Schoggins and
Rice, 2011).
To counteract the host cell's defense mechanisms, many viruses
express proteins that suppress or delay innate immune responses
(Haller et al., 2006; Randall and Goodbourn, 2008; Versteeg and
Garcia-Sastre, 2010). Previous studies have implicated multiple pro-
teins of porcine reproductive and respiratory syndrome virus (PRRSV)
in suppressing the type I IFN response [reviewed in (Fang and Snijder,
2010; Ke and Yoo, 2017; Lunney et al., 2016; Snijder et al., 2013)].
PRRSV is an enveloped, positive-stranded RNA virus, which belongs to
the order Nidovirales, family Arteriviridae. The family also includes
equine arteritis virus (EAV), mouse lactate dehydrogenase-elevating
virus (LDV), simian hemorrhagic fever virus (SHFV) [reviewed in
(Snijder et al., 2013)], and a number of more recently identiﬁed
members, many of which are of simian origin (Gulyaeva et al., 2017;
Kuhn et al., 2016). Historically, PRRSV isolates have been divided into
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two distinct genotypes, European genotype (Type 1) and North Amer-
ican genotype (Type 2), which were recently promoted to the species
level and named PRRSV-1 and PRRSV-2, respectively (Gulyaeva et al.,
2017). For both species, the genome is about 15 kb in length and
contains at least 11 open reading frames (ORFs). The replicase gene is
composed of ORF1a and ORF1b and occupies the 5’-proximal three-
quarters of the viral genome. It encodes two large nonstructural poly-
proteins, pp1a and pp1ab, with the expression of the latter depending
on -1 programmed ribosomal frameshift in the short ORF1a/ORF1b
overlap region. The PRRSV pp1a and pp1ab precursors are processed
into at least 14 functional nonstructural proteins (nsps) by a complex
proteolytic cascade that is directed by four ORF1a-encoded protease
domains: three papain-like proteases (PLP1α and PLP1β in nsp1α and
nsp1β, respectively, and PLP2 in the N-terminal region of nsp2) and a
chymotrypsin-like serine protease (SP) located in nsp4. PLP1α, PLP1β,
and PLP2 cleave the junctions between nsp1α/1β, nsp1β/2, and nsp2/
3, respectively, thus mediating the rapid release of nsp1α, nsp1β, and
nsp2 from the nascent polyproteins (Fang and Snijder, 2010). The nsp2
is the largest viral protein, and previous studies suggest that, in addition
to its functions directly related to viral replication, it also serves as an
innate immune antagonist (Beura et al., 2010; Frias-Staheli et al., 2007;
Sun et al., 2010, 2012; van Kasteren et al., 2012). Frias-Staheli et al.
(2007) ﬁrst demonstrated that PRRSV-2 nsp2 exhibits general deubi-
quitinase (DUB) activity towards cellular ubiquitin (Ub) conjugates and
showed deISGylation activity to remove the conjugates of the IFN-in-
duced Ub homolog ISG15. The DUB activity of the PRRSV PLP2 domain
was further characterized in an in vitro expression system for both
PRRSV species (van Kasteren et al., 2012). The de-ISGylation activity of
the PRRSV-1 PLP2 domain was observed in both in vitro expression
system and infected porcine alveolar macrophages (Sun et al., 2012),
although the level of de-ISGylation activity of puriﬁed PRRSV-2 PLP2
needs to be evaluated in more detail (Deaton et al., 2014). The
Fig. 1. PRRSV nsp2 variants suppress type I IFN production. (A) A schematic diagram of individual PRRSV nsp2 variants (nsp2, nsp2TF and nsp2N) and domains [PLP2,
nsp2(599–1233), nsp2TF(599–1402) and nsp2(599–1579)]. The numbers show both N- and C-terminal residues on polyprotein 1a for each individual protein. The catalytic residues of the PLP2
domain are labeled as Cys437 and His506. (B) Expression of nsp2-related proteins were evaluated by western blot analysis using anti-FLAG M2 mAb. GAPDH was detected as loading
control. Rabbit pAb against the unique nsp2 C-terminus was used to conﬁrm the expression of nsp2 and nsp2(599–1579), while rabbit pAb against unique nsp2TF C-terminus was used to
conﬁrm the expression of nsp2TF and nsp2TF(599–1402). (C) Eﬀect of nsp2-related proteins on the expression of IFN-β promoter-driven luciferase expression. HEK-293T cells were
cotransfected with a plasmid expressing individual nsp2-related proteins or domains, p125-Luc reporter plasmid expressing ﬁreﬂy luciferase under the control of the IFN-β promoter
(0.5 μg), and pRL-SV40 reporter plasmid (20 ng). An empty vector (EV) was used as a control. At 24 h posttransfection, cells were stimulated with SeV at 100 HA units/mL or for 16 h. Cell
lysates were harvested for measuring luciferase activity. Relative luciferase activities were calculated by normalizing the ﬁreﬂy luciferase to Renilla luciferase activities; the relative
luciferase activity in cells with EV-transfection and SeV stimulation was set as 100%. The mean value and SEM of representative experiments are shown. All experiments were repeated at
least three times, and duplicates were performed each time.
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biological signiﬁcance of these activities was supported by the ability of
PLP2 to inhibit type I IFN activation and antagonize the antiviral eﬀect
of ISG15 (Beura et al., 2010; Sun et al., 2012; van Kasteren et al., 2012).
Recently, in all arteriviruses except for EAV, a new ORF was dis-
covered that overlaps the nsp2-coding region of ORF1a in the –2/+1
reading frame (Fang et al., 2012). This ORF is translated via a unique –2
programmed ribosomal frameshift (PRF) mechanism, which produces a
previously unknown transframe product (nsp2TF) consisting of ap-
proximately the N-terminal two-thirds of nsp2 and a unique C-terminal
extension that is speciﬁed by the novel TF ORF (Fang et al., 2012).
Remarkably, the same frameshift site was also found to direct an eﬃ-
cient -1 PRF, which is followed by a stop codon, thus yielding a second
truncated nsp2 variant named nsp2N (Fang et al., 2012; Li et al., 2014).
Our recent work demonstrated that eﬃcient –2 and –1 PRF at this site
in the nsp2-coding region depends on the transactivation of frame-
shifting by the upstream replicase subunit nsp1β, which is thought to
bind together with cellular poly(C) binding proteins to the genomic
region containing the –2/–1 PRF signal, possibly to form a roadblock for
the translating ribosome (Li et al., 2014; Napthine et al., 2016).
The newly identiﬁed nsp2TF and nsp2N proteins add to the func-
tional complexity of the nsp2 region of the viral replicase, a region that
has also been explored in the context of the development of genetically
modiﬁed live virus (MLV) vaccines [reviewed in (Fang and Snijder,
2010; Lunney et al., 2016)]. Importantly, nsp2, nsp2TF, and nsp2N all
include the N-terminal PLP2 domain, which has been implicated in
disrupting type I interferon signaling by deubiquitination and deISGy-
lation of cellular proteins, as outlined above. In this study, we analyzed
the eﬀect of nsp2TF and nsp2N expression on host innate immune re-
sponses, both in an in vitro expression system and using recombinant
viruses with impaired nsp2TF/nsp2N expression. An immune gene
mRNA proﬁling system was employed to analyze the expression of a
predeﬁned set of 579 immune genes in cells infected with wild-type or
nsp2TF/nsp2N-deﬁcient viruses. A panel of innate immune genes was
found to be upregulated in cells infected with nsp2TF/nsp2N-deﬁcient
viruses. Subsequent in vivo studies consistently showed that nsp2TF/
nsp2N-deﬁcient viruses were less capable of interfering with the innate
immune response in infected pigs. These studies provide important
insights into the potential role(s) of PRRSV nsp2TF and nsp2N in the
modulation of host innate immune responses.
2. Results
2.1. In vitro expression of PRRSV nsp2TF or nsp2N aﬀects cellular innate
immune responses
To investigate the innate immune suppression capability of nsp2TF
and nsp2N, we expressed them individually in the context of a luci-
ferase reporter assay, which is based on the expression of a ﬁreﬂy lu-
ciferase reporter gene under the control of an IFN-β promoter
(Yoneyama et al., 1996). IFN-β signaling was activated by infection
with Sendai virus and the luciferase expression level was measured at
16 h after stimulation. PRRSV sequences (PRRSV-2, strain SD95-21)
encoding full-length nsp2, nsp2TF, or nsp2N were expressed as an N-
terminally FLAG-tagged fusion protein using a eukaryotic expression
vector (Fig. 1A). The empty vector (EV) and a plasmid expressing the
FLAG-tagged PLP2 domain, pFLAG-PLP2, were included as negative
and positive controls, respectively. Similar transfection rate of ~80%
was conﬁrmed by immunoﬂuorescence assay in HEK-293T cells trans-
fected with these expression constructs (Fig. S1). No obvious cytotoxic
eﬀects of protein expression were observed in transfected cells as de-
termined by cell viability assay (Fig. S2). Protein expression was eval-
uated by western blot analysis (Fig. 1B). Of note, many nsp2-related
proteins of smaller size (less than 100 kDa) were detected using the
antibody (M2) recognizing the N-terminal FLAG-tag, yielding a similar
pattern (with some exceptions) for the constructs expressing nsp2,
nsp2TF, and nsp2N. This suggested that these products are C-terminally
truncated expression products of distinct size.
In line with previous studies (Sun et al., 2010, 2012; van Kasteren
et al., 2012), expression of PLP2 strongly suppressed luciferase reporter
gene expression from the IFN-β promoter following SeV infection. Ex-
pression of nsp2, nsp2TF, and nsp2N showed inhibitory eﬀects on the
IFN-β promoter activity, as indicated by around 60%, 80%, and 90%
reduction of luciferase activity, respectively, in comparison to EV-
transfected control cells (Fig. 1C). Next, to assess whether these in-
hibitory eﬀects were directly linked to PLP2's protease/DUB activity,
we engineered a panel of constructs in which the PLP2 catalytic re-
sidues Cys437 and His506 were both substituted with alanine (C/H>A).
In HEK-293T cells transfected with these constructs, nsp2-related pro-
teins were expressed (Fig. 1B). Most of the nsp2-related proteins of
smaller size were also observed, suggesting these proteins did not result
from PLP2-mediated cleavage of the expression products. Surprisingly,
expression of nsp2TF-C/H>A and nsp2N-C/H>A still signiﬁcantly
inhibited IFN-β signaling following SeV stimulation (about 50% and
70% reduction compared to EV-transfected control cells). In contrast, in
the context of the expression of full-length nsp2 or the PLP2 domain
only, introduction of the PLP2-C/H>A mutation strongly impaired its
ability to inhibit luciferase expression (Fig. 1C). Compared to the PLP2
construct, nsp2TF and nsp2N contain an additional 804 amino acids (aa
599–1402) and 635 amino acids (aa 599–1233), respectively. Our data
suggested that, besides the PLP2/DUB domain, the downstream se-
quences of nsp2TF [nsp2TF(599–1402), see Fig. 1A] and nsp2N
[nsp2(599–1233), see Fig. 1A] could also contain activities that antag-
onize innate immune signaling. Consistent with this hypothesis, the
ectopically expressed nsp2TF(599–1402) and nsp2(599–1233) exhibited
strong inhibitory eﬀects on IFN-β promoter activity (about 70% and
80% reduction) in comparison to that of EV control (Fig. 1C).
Since PLP2 was reported to also act as a deubiquitinase (Deaton
et al., 2014; Frias-Staheli et al., 2007; Sun et al., 2010; van Kasteren
et al., 2012), we further compared the eﬀect of full-length nsp2,
nsp2TF, and nsp2N on host cell protein ubiquitination. HEK-293T cells
were transfected with a plasmid expressing HA-tagged ubiquitin and a
plasmid expressing FLAG-tagged full-length nsp2, nsp2TF, or nsp2N.
Again, the plasmid expressing the PLP2 domain and the empty vector
were used as controls. As shown in Fig. 2A, expression of all four PLP2-
containing products resulted in a decreased level of ubiquitin-con-
jugated proteins, but compared to full-length nsp2 and nsp2TF, nsp2N
had a stronger eﬀect and its DUB ability was comparable to that of the
PLP2 domain. Subsequently, we analyzed the eﬀect of nsp2TF and
nsp2N expression on cellular protein ISGylation. In HEK-293T cells,
ISG15 conjugates were generated by co-transfecting plasmids expres-
sing ISG15 and three conjugation enzymes E1, E2, and E3. Cells were
co-transfected with plasmids expressing one of the individual nsp2-re-
lated proteins. Co-expression of either nsp2TF or nsp2N resulted in a
clear decrease in the level of ISGylated cellular proteins (Fig. 2B). To
directly link the DUB and deISGylation activity to the PLP2 domain of
these proteins, we repeated the assays using the respective C/H>A
mutants. As shown in Fig. 2, compared to cells expressing the wild type
nsp2-related proteins, much higher levels of ubiquitin and ISG15 con-
jugation were detected in cells expressing any of the corresponding C/
H>A mutants. Taken together, these data revealed that individually
expressed nsp2, nsp2TF, and nsp2N have the ability to interfere with
cellular protein ubiquitination and ISGylation processes to variable
degrees, with nsp2N showing the strongest eﬀect. Moreover, the de-
conjugating activities of these nsp2-related proteins can be impaired by
inactivating their PLP2 activity.
2.2. Construction and characterization of in vitro properties of nsp2TF/
nsp2N-deﬁcient mutants
To determine whether the immune suppression potential of nsp2TF
and nsp2N observed in in vitro expression systems reﬂect their actual
function in PRRSV-infected cells, we employed a previously described
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strategy to create PRRSV-1 and PRRSV-2 mutants that are partially or
completely deﬁcient in expression of nsp2TF/nsp2N (Fang et al., 2012;
Li et al., 2014). For the present study, PRRSV-2 mutants were analyzed,
in which -2/-1 PRF-inactivating mutations were engineered in the full-
length cDNA clone of PRRSV-2 strain SD95-21 (Fig. 3A). Mutant vSD95-
21-KO1 (vKO1) retained an intact PRF signal, meaning that the relative
translation of the three diﬀerent ORFs should not be aﬀected. However,
whereas production of nsp2 and nsp2N was unchanged, nsp2TF was
truncated due to the insertion of three stop codons in the TF ORF, re-
sulting in the production of a C-terminally truncated form of nsp2TF
(98.5 kDa, indicated by a red arrow in Fig. 3B). Mutant vSD95-21-KO2
(vKO2) carried a combination of mutations that disrupt the PRF
slippery sequence and the downstream PRF-stimulatory CCCANCUCC
motif. These mutations were previously shown to fully inactivate the
PRRSV -2/-1 PRF without aﬀecting nsp2 expression, since all mutations
used were translationally silent with respect to ORF1a (Fang et al.,
2012; Li et al., 2014). As shown in Fig. 3B, the expression of nsp2 ap-
peared not to be aﬀected in MARC-145 cells infected with either of
these mutants. In comparison to the WT virus in MARC-145 cells, re-
plication of vKO1 and vKO2 mutants was impaired, with 1- to 2-log
decreased virus titers before 48 hpi. The peak titer of vKO2 was 0.5-log
lower than that of WT virus, while vKO1 reached a similar peak titer as
WT virus 12 h later (at 60 hpi, Fig. 3C).
Fig. 2. The de-ubiquitination and de-
ISGylation activities of PRRSV nsp2 re-
lated proteins. (A) Eﬀect of nsp2 related
protein expression on ubiquitin conjugation.
HEK-293T cells were co-transfected with
plasmid DNAs expressing HA-Ub and FLAG-
tagged nsp2, nsp2TF, nsp2N, PLP2 or their
catalytic site mutants (nsp2-C/H>A,
nsp2TF-C/H>A, nsp2N-C/H>A, PLP2-C/
H>A). HA-Ub conjugated cellular proteins
were visualized by western blot analysis
using anti-HA mAb. The expression of FLAG-
tagged nsp2 related proteins was detected
by anti-FLAG M2 mAb. (B) HEK-293T cells
were co-transfected with plasmid DNAs ex-
pressing ISG15 and its conjugation enzymes
E1/E2/E3, FLAG-tagged nsp2, nsp2TF,
nsp2N, PLP2 or their catalytic site mutants
(nsp2-C/H>A, nsp2TF-C/H>A, nsp2N-C/
H>A, PLP2-C/H>A). ISG15-conjugated
cellular proteins were detected by ISG15
speciﬁc mAb in western blot analysis. The
expression of FLAG-tagged nsp2 related
proteins was detected by anti-FLAG M2
mAb. For both assays, the empty p3xFLAG
vector plasmid was included as a control,
while expression of housekeeping gene
GAPDH was detected as a loading control.
Fig. 3. Construction and in vitro char-
acterization of nsp2TF/nsp2N-deﬁcient
mutants. (A) Nucleotide sequences in the
regions of mutations created in nsp2TF/
nsp2N-deﬁcient mutants. KO1, knockout mu-
tant 1 (premature termination codons in TF
ORF); KO2, knockout mutant 2 (premature
termination codon and disrupted frameshift
signal). Mutated nucleotides are shown in red.
(B) Radioimmunoprecipitation detection of
nsp2-related proteins in virus infected cells.
MAb 140-68 was used to recognize the
common N-terminal PLP2 domain. The trun-
cated nsp2TF in vKO1-infected cells is in-
dicated with a red arrow. (C) Multiple-step
virus growth curve. Each data point shown
represents the mean value from duplicates,
and error bars show SEM.
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2.3. Cellular immune gene expression is strongly upregulated in cells
infected with nsp2TF/nsp2N-deﬁcient PRRSV
To investigate whether impaired nsp2TF/nsp2N expression would
alter the ability of PRRSV to interfere with cellular immune gene ex-
pression, an immune gene mRNA expression proﬁle was determined for
MARC-145 cells (a cell line of African green monkey origin) infected
with WT PRRSV-2 strain SD95-21 and mutants vKO1 and vKO2. Since
there is no monkey gene speciﬁc nCounter kit commercially available,
we used the nCounter system that was designed for simultaneously
analyzing the expression of a predeﬁned set of 579 human immune
genes (Human_Immunology_v2_Panel; NanoString Technologies,
Seattle, WA). In comparison to mock-infected cells, a total of 11 dif-
ferentially expressed genes (DEGs) were identiﬁed in WT virus-infected
cells, while 96 and 78 DEGs were identiﬁed in cells infected with vKO1
and vKO2, respectively (Fig. 4A, Table S1). Among these hits, 10, 94,
and 75 DEGs were upregulated in cells infected with WT virus, vKO1,
and vKO2, respectively. Venn diagram analysis showed that the ex-
pression of 9 immune genes was upregulated in cells infected with all
three viruses, whereas 63 DEGs were upregulated only in cells infected
with either vKO1 or vKO2, and 1, 22, and 3 DEGs were speciﬁcally
upregulated in cells infected with WT virus, vKO1, and vKO2, respec-
tively (Fig. 4B, Table S3). In comparison to WT virus, vKO1 and vKO2
infection upregulated the expression of 84 and 65 more immune genes
in host cells, respectively. To identify biological pathways associated
with the identiﬁed DEGs, we performed a KEGG pathway enrichment
analysis using the DAVID program (Huang et al., 2009a, 2009b) to
identify pathways that were consistently enriched in target cells
(Fig. 4C, Table S2). The cytokine and cytokine receptor interaction and
TNF signaling pathway were enriched pathways in WT virus-infected
cells. By contrast, there were many additional pathways enriched in
cells infected with vKO1 and vKO2, and the most strongly activated
pathways identiﬁed were those involved in cytokine-cytokine receptor
interaction, TNF signaling, Toll-like receptor signaling, NOD-like re-
ceptor signaling, NF-κB signaling, RIG-I-like receptor signaling, che-
mokine signaling, JAK-STAT signaling, cytosolic DNA-sensing, and
natural killer cell mediated cytotoxicity. Most of these strongly acti-
vated pathways are involved in the host cell's innate immune response.
To better understand the DEGs and visualize relevant activated
pathways, the protein-protein interactions (PPI) networks of DEGs
identiﬁed in infected cells were generated using the Search Tool for the
Retrieval of Interacting Genes/Proteins (STRING), which is a database
that provides a critical assessment and integration of protein–protein
interactions, including direct (physical) as well as indirect (functional)
associations (Szklarczyk et al., 2015). Consistent with the KEGG
pathway enrichment analysis using DAVID, all enriched pathways in
vKO1- and vKO2-infected cells identiﬁed above were signiﬁcantly ac-
tivated in PPI networks, while only cytokine-cytokine receptor inter-
action and TNF signaling pathways were signiﬁcantly activated path-
ways in WT virus-infected cells. The representative enriched pathways
in cells infected with WT, KO1 virus, and KO2 virus were highlighted in
the protein-protein interactions networks of DEGs, respectively (Fig.
S3).
The above data analysis showed that most of the pathways activated
by vKO1 and vKO2 infection are involved in the host's innate immune
response. Next, we performed quantitative RT-PCR (qRT-PCR) to
Fig. 4. nCounter mRNA Proﬁling of immune gene expression
in virus-infected cells. (A) An overview on the number of dif-
ferentially expressed genes (DEG) in virus-infected cells at 12 hpi.
(B) Common and uniquely upregulated DEGs in virus-infected
cells at 12 hpi. (C) Enriched functional categories of DEGs in
virus-infected cells at 12 hpi determined by KEGG Pathway
Enrichment analysis using DAVID (Huang et al., 2009a, 2009b).
P-values adjusted by Benjamini-Hochberg correction less than
0.05 were deﬁned as signiﬁcant enrichment. The x-axis is the
negative log10 of P-value.
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independently verify the gene expression levels of six representative
innate immune genes: IFN-α, IFN-β, IRF7, IL-28A, IFIH1, and IFITM1.
Based on the analysis using the nCounter system, these genes had sig-
niﬁcantly higher expression levels in vKO1- and vKO2-infected cells
than in WT virus-infected cells (Fig. 5A). Using the same RNA samples
for multiplex digital mRNA proﬁling, the expression levels of these
genes were evaluated with commercially available TaqMan Gene Ex-
pression assays (Thermoﬁsher Scientiﬁc, Waltham, MA), and their re-
lative expression levels were calculated. The TaqMan probes were
speciﬁcally designed for the targeted monkey genes. As shown in
Fig. 5B, the relative gene expression levels of the six innate immune
genes generally were highly consistent with the data generated using
the nCounter system (Fig. 5A).
To further conﬁrm the results generated using nCounter and
TaqMan analysis, the ability of WT and mutant viruses to stimulate the
expression of this panel of representative genes was veriﬁed in porcine
alveolar macrophages (PAM), the primary target cell of PRRSV in in-
fected animals. PAM cells were infected with the WT and mutant
viruses at an MOI of 1, and harvested at 12 hpi. Swine gene speciﬁc
qRT-PCR assays were used to analyze the expression levels of the se-
lected immune genes. Consistent with the increased expression levels
detected in MARC-145 cells, vKO1 and vKO2 induced signiﬁcantly
higher expression levels of IFN-α, IFN-β, IRF7, IL-28B, IFIH1, and
IFITM1 in PAM cells (Fig. 5C).
2.4. Eﬀect of nsp2TF/nsp2N deﬁciency on innate and cell-mediated
immune responses in PRRSV-infected pigs
To assess whether the in vitro data described above could be re-
produced in PRRSV-infected pigs, we investigated the impact of
nsp2TF/nsp2N-deﬁcient mutations on innate immune responses in
PRRSV-infected nursery pigs. Four groups of pigs (n=9) were used,
which were infected with WT virus (group 1), vKO1 (group 2), vKO2
(group 3), while the negative control group (group 4) was kept unin-
fected. To verify that WT and both mutant viruses replicated in vivo,
serum samples collected by 6 days post infection (DPI) were used for
virus isolation on MARC-145 cells. Virus was recovered from the serum
samples of the pigs in groups 1–3, indicating active replication of WT
and mutant viruses in pigs. The mutations introduced into the vKO1
and vKO2 genomes were found to be genetically stable throughout the
study, as determined by sequencing of RT-PCR products derived from
serum samples of vKO1- and vKO2-infected pigs at 21 dpi. Viral load in
serum samples collected at 1, 2, 6, 21, 28 DPI was further quantiﬁed by
qRT-PCR. The results showed reduced viral loads in pigs infected with
vKO1 and vKO2, which is consistent with the observations made in cell
culture (Fig. 3C). At 1, 2 and 21 DPI, the group of pigs infected with
vKO1 had signiﬁcantly lower viral load (0.5–1.2 logs lower) than those
pigs infected with WT virus (Fig. 6A, B and D). At 2, 6 and 21 DPI, viral
loads in serum of vKO2-infected pigs were about 0.9–2 logs lower than
those of WT virus-infected pigs (Fig. 6B-D).
Fig. 5. Quantitative RT-PCR detection of the expression of selected diﬀerentially expressed genes in virus-infected cells. (A) Six selected immune genes with increased expression
levels in cells infected by nsp2TF/nsp2N-deﬁcient mutants. Each data point shown represents the mean value from ﬁve replicates, and the gene expression levels in mock were treated as
1. (B) The relative expression levels of six immune genes in virus-infected MARC-145 cells at 12 hpi. (C) The relative expression levels of six immune genes in virus-infected PAM at
12 hpi. (B-C) Each data point shown represents the mean value from ﬁve replicates, and the gene expression levels in WT infected cells were treated as 1.
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Fig. 5. (continued)
Fig. 6. Comparison of viral RNA loads in serum samples from pigs inoculated with the WT virus and nsp2TF/nsp2N-deﬁcient mutants. Pigs were uninfected (mock) or infected
with WT PRRSV (WT), vKO1 or vKO2 mutant. Serum samples were collected on the indicated days post-infection. Viral loads in serum samples quantiﬁed by quantitative RT-PCR and
calculated as viral RNA copies per milliliter. Statistical signiﬁcance between the WT virus-infected group and mutant virus-infected groups was determined by one-way ANOVA (Tukey's
test) and indicated with asterisks (*, P< 0.05; **, P< 0.01; ***, P< 0.001).
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To assess innate immune responses, IFN-α production in serum
samples at 1, 2 and 6 DPI was initially evaluated with a ProcartaPlex
Porcine IFN alpha Simplex kit (eBioscience, San Diego, CA). Compared
with WT virus, vKO1 and vKO2 infection induced an earlier IFN-α re-
sponse (Fig. 7A). Although similar peak concentrations of IFN-α were
detected in all three groups of infected pigs, IFN-α level peaked one day
earlier (at 1 DPI) in pigs infected with vKO1 and vKO2 compared to pigs
infected with WT-virus. Of note, the IFN-α production in pigs correlated
well with the viral loads that were measured (Fig. 6). In terms of IFN-α
titer and viral load, the largest diﬀerence between WT virus and mutant
virus infection groups was observed at 2 DPI.
The IFN-α response is critical for natural killer (NK) cell-mediated
cytotoxicity. In our nCounter analysis, the genes associated with the NK
cell cytotoxicity pathway were enriched in vKO1- and vKO2-infected
cells (Fig. 4C; Table S2). Therefore, we further evaluated NK cell-
mediated cytotoxicity in our experimentally infected pigs. Peripheral
blood mononuclear cells (PBMCs) isolated from pigs infected with
vKO1, vKO2 and WT virus were used as a source of NK cells (eﬀectors;
E) to evaluate NK cell cytotoxic activity using human myeloblastoid
K562 cells as target (T) cells. At both E:T ratios used (100:1 and 50:1),
increased NK cell cytotoxicity was observed in PBMCs from vKO1 and
vKO2-infected pigs at 6 DPI (Fig. 7B).
A strong innate immune response following a viral infection is ex-
pected to enhance the cell-mediated adaptive immunity (Iwasaki and
Medzhitov, 2015; Jain and Pasare, 2017). We further measured the fre-
quency of diﬀerent T cell subpopulations in PBMCs. Swine T cells ex-
pressing the combination of phenotypic markers CD3+CD4+CD8α- are T-
helper cells, and cells with CD3+CD4-CD8αβ+ are exclusively cytotoxic T
lymphocytes (CTLs) (Sinkora and Butler, 2009; Talker et al., 2013). In the
current study, PBMCs isolated at 6, 21 and 28 DPI were restimulated with
WT virus and immunostained cells were analyzed by ﬂow cytometry to
identify the important T cell subsets. This analysis showed that the fre-
quency of T-helper cells in PBMCs from vKO1-infected pigs was sig-
niﬁcantly increased by DPI 28 compared to that from mock-infected pigs
(Fig. 8A), while the frequencies of cytotoxic T cells were signiﬁcantly in-
creased in PBMCs from both vKO1- and vKO2-infected pigs compared to
that from mock-infected animals (Fig. 8B). These data indicate that the NK
cells and the two important T cell subsets were activated, particularly in
vKO1/vKO2-infected pigs, suggesting that early activation of innate im-
mune responses following infection with nsp2TF/nsp2N-deﬁcient mutants
could enhance the innate and cell-mediated adaptive immunity, in com-
parison to an infection with WT virus.
3. Discussion
PRRSV infection is known to elicit poor innate immune responses
(Albina et al., 1998; Buddaert et al., 1998; Luo et al., 2008; Miller et al.,
2004; Van Reeth et al., 1999). Previous studies identiﬁed the nsp2
PLP2/DUB domain as a major innate immune antagonist (Frias-Staheli
et al., 2007; Sun et al., 2010, 2012; van Kasteren et al., 2012). The
recently identiﬁed nsp2TF and nsp2N proteins (Fang et al., 2012; Li
et al., 2014) share their N-terminal ~850 amino acid residues with
nsp2, including the PLP2 domain, which raised the question whether all
three nsp2 variants are individually able to antagonize the innate im-
mune response in infected cells. Potentially, they could exhibit diﬀerent
substrate speciﬁcities, a possibility that was highlighted by the previous
observation that nsp2 and nsp2TF, which include diﬀerent predicted
transmembrane domains, appear to localize to diﬀerent intracellular
membrane structures (Fang et al., 2012), whereas the truncated nsp2N
is predicted to be a cytosolic protein.
In this study, we compared the ability of full-length nsp2, nsp2TF
and nsp2N to suppress the host innate immune response. These proteins
were initially analyzed in an in vitro expression system and the results
suggested that nsp2TF and nsp2N expression results in a much stronger
inhibitory eﬀect on type I IFN production. The deubiquitylation and
deISGylation assays consistently showed that all three proteins have the
ability to interfere with these processes which act on host cell (or viral)
substrates, while nsp2N showed the strongest inhibitory eﬀects.
Interestingly, mutations targeting the catalytic residues of the PLP2
domain impaired the DUB and deISGylation activities of nsp2TF and
nsp2N, but did not completely impair its immune suppression function,
as demonstrated in the luciferase reporter assay (Fig. 1C). The data
suggest that sequences downstream of the PLP2 domain of nsp2TF and
nsp2N are also capable of suppressing innate immune functions
(Fig. 1C). This may explain why in all assays nsp2N expression inter-
fered most strongly with innate immune signaling. The activity of this
part of nsp2N may depend on the localization, conformation or inter-
actions of the protein, as both nsp2 and nsp2TF also contain this do-
main, but do not appear to counter innate immunity at the same level.
Obviously, we cannot formally exclude the possibility that the
properties and/or relative activities of the three nsp2 variants may be
diﬀerent in virus-infected cells, which is why we proceeded to carefully
compare the impact on the innate and cell-mediated immune (CMI)
response of infection with WT virus and mutants vKO1 and vKO2,
which lack expression of functional nsp2TF and nsp2TF/nsp2N, re-
spectively. The results obtained were consistent with those from the in
vitro expression systems, with both mutants showing a clearly impaired
ability to suppress innate immune gene expression. DEG proﬁles iden-
tiﬁed speciﬁc biological pathways that were consistently upregulated in
vKO1- or vKO2-infected cells. Most of these pathways are involved in
host innate immune responses, including RIG-I-like receptor signaling
pathway, Jak-STAT signaling pathway, and NF-κB signaling pathway.
These data are also consistent with previous reports that PLP2 has the
ability to interfere with the ubiquitination of RIG-I and IκB, thus
Fig. 7. Comparison of IFN-α production
levels and NK cell cytotoxicity in pigs
inoculated with WT virus and nsp2TF/
nsp2N-deﬁcient mutants. Pigs were unin-
fected (mock) or infected with WT PRRSV
(WT), vKO1 or vKO2 mutant. (A) IFN-α le-
vels in serum samples collected at 0, 1, 2
and 6 DPI were analyzed with a
ProcartaPlex Porcine IFN alpha Simplex kit.
(B) PBMCs (NK eﬀectors) harvested on the
day of necropsy (6 DPI) were co-cultured
with target cells (K562) at an E:T ratio of
100:1 or 50:1. After overnight incubation,
ﬂow cytometry was performed to evaluate
the NK cell-speciﬁc cytotoxic activity. Each
data point represents the mean value and
SEM of data from 3 pigs. Statistical sig-
niﬁcance between the wild-type virus in-
fected group and mutant virus-infected
groups was determined by one-way ANOVA (Tukey's test) and indicated with asterisks (*, P<0.05; **, P<0.01; ***, P<0.001).
Y. Li et al. Virology xxx (xxxx) xxx–xxx
8
suppressing RIG-I-mediated innate immune signaling, including NF-κB
activation and downstream eﬀects on the Jak-STAT pathway towards
ISG expression (Sun et al., 2010, 2012; van Kasteren et al., 2012). Since
the nCounter assay was originally designed for analyzing human gene
expression, while our DEG proﬁling was conducted using PRRSV-in-
fected MARC-145 cells (a cell line of African green monkey origin), we
further conﬁrmed the DEG proﬁling results using cytokine qRT-PCR to
detect innate immune genes expression in PRRSV-infected MARC-145
cells as well as in PRRSV-infected swine macrophages. The results
consistently showed that, compared to infection with WT virus, type I
IFN (IFA 1/13, IFNB1), type III IFN (IL28B), and ISGs (IRF7, IFIH1 and
IFITM1) are strongly upregulated in both MARC-145 cells and swine
macrophages infected with the vKO1 and vKO2 mutants, which further
implicates nsp2TF/nsp2N in innate immune suppression.
In both vKO1- and vKO2-infected cells, the nsp2 expression was not
aﬀected. The data from the in vitro expression system and virus infec-
tion condition made us speculate that nsp2TF and/or nsp2N might have
evolved diﬀerent mechanism(s) from nsp2 in the suppression of the
host innate immune response. In PRRSV-infected cells, nsp2TF was
found to be targeted to a diﬀerent location from full-length nsp2 (Fang
et al., 2012), i.e. the membranes of the exocytic pathway rather than the
replication structures formed from modiﬁed ER membranes, a process
in which nsp2 is one of the key players (Knoops et al., 2012; Oudshoorn
et al., 2016). It is also worth noting that, while the TF region of nsp2TF
contains a predicted TM domain, nsp2N does not contain any predicted
TM domain, meaning it could be a cytosolic protein possessing unique
function(s). This is also supported by the observed activity in sup-
pression of innate immune signaling exerted by the nsp2N part down-
stream of PLP2, which is apparently not related to DUB activity. The
mechanistic aspects of the role of PRRSV nsp2TF and nsp2N in coun-
teracting host innate immune response need to be further studied.
Besides the panel of innate immune cytokine genes showing sig-
niﬁcant upregulation in vKO1- and vKO2-infected cells, DEG proﬁling
also identiﬁed other upregulated genes which are associated with cel-
lular signaling pathways. Some of these are linked to pathways of the
CMI response. It is worth noting here that the expression of the DEGs
associated with the antigen processing and presentation pathway was
also upregulated in vKO1- and vKO2-infected cells, more speciﬁcally
the expression of the human leukocyte antigen (HLA-B), which is re-
lated to major histocompatibility complex (MHC) class I (Table S1). In
comparison to mock-infected cells, a 13% decrease (statistically sig-
niﬁcant) of HLA-B expression was observed in WT virus-infected cells;
in contrast, expression of HLA-B was 3- and 2.5-fold increased in cells
infected with vKO1 and vKO2, respectively. Since the KO1 mutations
result in the expression of a C-terminally truncated form of nsp2TF,
without aﬀecting nsp2 and nsp2N expression, the data suggest that
nsp2TF could be involved in modulating the expression of HLA-B. The
HLA complex encodes the MHC proteins, which are expressed on the
cell surface for the regulation of the human immune system (Janeway
et al., 2001). In pigs, the corresponding gene complex is termed swine
leukocyte antigen (SLA-1). The HLAs/SLAs present peptides on the cell
surface, which are derived from proteins (both native and foreign)
produced inside the cell. Upon virus infection, the HLA/SLA system
related to MHC class I presents viral peptides on the cell surface so that
infected cells can be recognized and destroyed by CD8+ cytotoxic T
cells (Bhardwaj et al., 1994; Janeway et al., 2001). Previous studies
showed that PRRSV infection down-regulates the expression of SLA
class I (SLA-1) in macrophages and dendritic cells (Du et al., 2015; Park
et al., 2008; Wang et al., 2007). More importantly, a recent study de-
monstrated that SLA-1 expression was down-regulated by the expres-
sion of nsp2TF, and the C-terminal 68 amino acids of the TF domain
were concluded to be critical for this activity (Cao et al., 2016). This
result is consistent with our ﬁndings presented here and further im-
plicates nsp2TF in the CMI response during PRRSV infection. This also
provides an insight into the possible molecular mechanism of impaired
CMI response in PRRSV infection. The involvement of nsp2TF in
modulation of the CMI response is currently under investigation in our
laboratory.
We further used a nursery pig model to assess the reduced ability of
nsp2TF/nsp2N-deﬁcient mutants to interfere with the innate immune
response in vivo. Both mutants were found to have attenuated growth in
pigs and no clinical symptoms or adverse side eﬀects of vKO1/2 in-
fection were observed (data not shown). Viable mutant viruses could be
isolated from the serum of infected pigs by 6 days post infection, de-
monstrating viral replication in pigs. Genome sequencing conﬁrmed the
stability of the mutations introduced in the nsp2 region of the vKO1/2
mutants. Compared to WT virus, both mutants produced lower viral
loads, with mutant vKO2 consistently being most impaired. In general,
IFN-α production in pigs correlated well with viral loads. In vKO1 and
vKO2 infected pigs, IFN-α reached peak titer one day earlier than that
in WT virus infected pigs. The stronger IFN-α response also correlated
well with NK cell-mediated cytotoxicity. In our nCounter analysis, the
NK cell cytotoxicity pathway was enriched in vKO1 and vKO2 infected
cells. At 6 DPI, increased NK cell cytotoxicity was observed in vKO1 and
vKO2-infected pigs. In addition, such a positive correlation is further
demonstrated by the results of increased activation of Th1 CMI re-
sponses in vKO1 and vKO2-infected pigs. Collectively, these data sug-
gest that expression of nsp2TF and nsp2N helps to delay the onset of the
innate immune response following PRRSV infection in pigs, which may
contribute to the weak induction of cell-mediated immunity during the
later stage of viral infection.
It was expected that the mutations introduced in vKO1 might have
Fig. 8. T-helper and cytotoxic T cell responses in pigs infected with WT virus and nsp2TF/nsp2N-deﬁcient mutants. PBMCs isolated at 6, 21 and 28 DPI were unstimulated or
restimulated with the WT virus. Cells were immunostained for pig speciﬁc markers CD3, CD4, CD8α and CD8β, and the frequency of each lymphocyte subset was grouped based on the
combination of markers: (A) CD3+CD4+CD8α- (T-helper cells) and (B) CD3+CD4-CD8αβ+ (cytotoxic T cells) after analysis by ﬂow cytometry. Statistical signiﬁcance between the groups
was determined by one-way analysis of variance (ANOVA) followed by Tukey's post hoc test. (*P<0.05; **P<0.01).
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less of an eﬀect on the ability of the virus to suppress host innate im-
mune responses, since they only C-terminally truncated nsp2TF without
preventing frameshifting and the expression of nsp2N (and a truncated
form of nsp2TF). Using our in vitro gene expression assays (Fig. 1C),
both nsp2TF and nsp2N were found to antagonize innate immune sig-
naling, with nsp2N expression having the strongest eﬀect. The vKO2
mutations knock out the expression of both nsp2TF and nsp2N, which
could have been expected to exert a stronger eﬀect. However, when
tested in the context of PRRSV infection, the qRT-PCR results con-
sistently showed higher cytokine gene expression levels in vKO1-in-
fected cells, although the diﬀerence was not statistically signiﬁcant.
Moreover, vKO1-infected pigs showed higher frequencies of T-helper
and cytotoxic T cells than vKO2-infected pigs (Fig. 8). One explanation
for this phenomenon could be the reduced ability of mutant vKO2 to
replicate in infected cells and animals compared to vKO1. Even if vKO1
has a lower intrinsic IFN-inducing potential than vKO2, this could be
compensated by a higher level of viral replication, eventually resulting
in a comparable or stronger stimulation of the immune responses in
infected cells or animals.
In conclusion, our results show that nsp2TF and nsp2N can mod-
ulate the host's innate immune responses against infection with PRRSV
and, most likely, other arteriviruses. Recombinant viruses with im-
paired expression of these frameshift-derived nsp2 variants are atte-
nuated upon infection of animals. Since the ribosomal frameshift site in
the nsp2-coding region is highly conserved among diﬀerent PRRSV
strains, manipulating the expression of nsp2TF and nsp2N may provide
a rational basis for developing improved PRRSV vaccines in the future.
4. Materials and methods
4.1. Viruses and cells
PRRSV-2 isolate SD95-21 (GenBank accession no. KC469618) and
its nsp2TF/nsp2N-deﬁcient mutants were used in all experiments. BHK-
21 cells were used for initial transfection and recovery of recombinant
viruses. MARC-145 cells were used for recombinant virus production
and subsequent experiments. These cells were maintained in minimum
essential medium (Invitrogen) supplemented with 10% heat-inactivated
fetal bovine serum and antibiotics (100 units/mL of penicillin, 100 µg/
mL of streptomycin and 0.25 µg/mL of fungizone) at 37 °C with 5%
CO2. Porcine alveolar macrophages (PAMs) were obtained by lung la-
vage of 6-week-old PRRSV-naive piglets using a method described
previously (Zeman et al., 1993). The Sendai virus (SeV) Cantell strain
was grown in embryonated chicken eggs, and virus titer was de-
termined by hemagglutination assay using chicken red blood cells as
described previously (Yonemitsu and Kaneda, 1999).
4.2. Plasmids
As indicated in Fig. 1A, a panel of plasmids expressing diﬀerent
regions of nsp2 was constructed by cloning corresponding viral
genomic sequences into plasmid vector p3xFLAG-Myc-CMV-24 (Sigma-
Aldrich, St. Louis, MO) using the restriction sites of NotI and BamHI.
This panel of plasmids was designated as pFLAG-nsp2, pFLAG-nsp2TF,
pFLAG-nsp2N, pFLAG-PLP2, pFLAG-nsp2(599–1233), pFLAG-
nsp2TF(599–1402) and pFLAG-nsp2(599–1579). In the nsp2TF construct, the
-2/-1 PRF region was modiﬁed to ensure expression of only nsp2TF
using QuickChange™ site-directed mutagenesis kit (Agilent Technolo-
gies, Santa Clara, CA). Based on these constructs, a panel of mutant
plasmids expressing nsp2-related proteins was created using Quick-
Change™ site-directed mutagenesis kit (Agilent Technologies, Santa
Clara, CA), in which PLP2 protease function was inactivated by in-
troducing alanine substitutions at Cys433 and His503 (C/H>A). This
panel of plasmids was designated as pFLAG-nsp2-C/H>A, pFLAG-
nsp2TF-C/H>A, pFLAG-nsp2N-C/H>A, or pFLAG-PLP2-C/H>A.
The full-length cDNA clones, pCMV-SD95-21 and pCMV-SD95-21-KO2,
were used to recover SD95-21 WT virus and mutant vKO2 as we de-
scribed previously (Li et al., 2014). To create a full-length cDNA clone
in which the TF ORF was truncated, three stop codons were introduced
using QuickChange™ site-directed mutagenesis kit to generate in-
fectious clone of pCMV-SD95-21-KO1 (Fig. 3A) (Fang et al., 2012). In
luciferase reporter assay, two reporter plasmids, the p125-Luc and pRL-
SV40 were used as described previously (Sun et al., 2010). The p125-
Luc reporter plasmid was kindly provided by Takashi Fujita (Yoneyama
et al., 1996) and expresses the ﬁreﬂy luciferase under the control of the
IFN-β promoter. The pRL-SV40 plasmid that expresses a Renilla luci-
ferase under the control of a simian virus 40 (SV40) promoter was
purchased from Promega (Madison, WI).
4.3. Antibodies
To detect the expression of nsp2, nsp2TF, nps2N and PLP2, the α-
FLAG monoclonal antibody (mAb) M2 (Sigma-Aldrich, St. Louis, MO)
and mAb 140-68 speciﬁc for the PRRSV-2 PLP2 domain were used. A
polyclonal antibody (pAb) speciﬁcally recognizing the unique C-term-
inal domain of nsp2TF was used to detect full-length nsp2TF (Li et al.,
2014). A rabbit pAb speciﬁcally recognizing the nsp2 C‐terminus was
used to detect full-length nsp2 (Guo et al., 2016). The mAb SDOW17
that is speciﬁc for the PRRSV nucleocapsid protein was used to detect
viral infection in cell culture (Nelson et al., 1993). The anti-GAPDH pAb
sc-25778 (Santa Cruz Biotechnology, Dallas, TX) was used to detect the
expression of housekeeping gene GAPDH.
4.4. Luciferase reporter assay
HEK-293T cells were transfected with 0.5 µg plasmid DNA of p125-
luc (a luciferase reporter plasmid containing IFN-β promoter), 20 ng
plasmid DNA of pRL-SV40, and 1.0 µg plasmid DNA expressing
3xFLAG-tagged nsp2, nsp2TF, nsp2N, nsp2(599–1233), nsp2TF(599–1402),
nsp2(599–1579), PLP2, nsp2-C/H>A, nsp2TF-C/H>A, nsp2N-C/H>A,
PLP2-C/H>A, or empty vector (EV). Transfection was conducted
using TransIT®-LT1 Transfection Reagent (Mirus Bio LLC, Madison, WI)
following the manufacturer's instructions. At 24 h post transfection,
cells were stimulated by infection with SeV at 100 HA unit per mL for
16 h. Cells were harvested and subjected to a reporter gene assay using
a dual luciferase reporter system (Promega, Madison, WI) according to
the manufacturer's instructions. Fireﬂy or Renilla luciferase activity was
measured in FLUOstar Omega (BMG Labtech). Relative luciferase ac-
tivities were calculated by normalizing the ﬁreﬂy luciferase to Renilla
luciferase activities. Cell lysates were further used on SDS-PAGE and
Western blot analysis to evaluate protein expression. To determine the
possible cytotoxicity caused by transfection and protein expression,
triplicate cell cultures were subjected to test cell viability using
CellTiter 96® AQueous One Solution Cell Proliferation Assay (MTS)
(Promega, Madison, WI), following the manufacturer's instructions.
4.5. Radioimmunoprecipitation
MARC-145 cells were infected with PRRSV WT or nsp2TF/nsp2N-
deﬁcient mutants at a multiplicity of infection (MOI) of 0.1 for 24 h.
After three washes with PBS, cells starved for 30 min in methionine-
and cysteine-free medium (Thermo Fisher Scientiﬁc, Waltham, MA).
Subsequently, protein synthesis in the infected cells was metabolically
labeled for 2 h in methionine- and cysteine-free medium supplemented
with 200 mCi [35S]methionine/cysteine mixture (Perkin-Elmer). After
labelling, cells were harvested in lysis buﬀer [20 mM Tris/HCl (pH 7.6),
150 mM NaCl, 1% NP-40, 0.1% sodium deoxycholate, 0.1% SDS] and
cell debris were removed by centrifugation. Immunoprecipitaion was
performed with mAb 140-68 that recognizes PLP2 domain of nsp2,
nsp2TF and nsp2N as described previously (Li et al., 2012). The protein
complexes were dissolved in Laemmli sample buﬀer and heated at 96 °C
for 6 min prior to loading onto Novex™ 6% Tris-Glycine Mini Gel
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(Thermoﬁsher scientiﬁc, Waltham, MA). Gel was dried and exposed to
autoradiography ﬁlm (Sigma-Aldrich, St. Louis, MO).
4.6. Western blot analysis
To evaluate protein expression in DNA-transfected or virus-infected
cells, western blot analysis was performed using the method described
previously (Li et al., 2016, 2013). Brieﬂy, cells were harvested with
passive lysis buﬀer of Dual-Luciferase® Reporter Assay System (Pro-
mega, Madison, WI) or Pierce IP Lysis Buﬀer (Thermo Fisher Scientiﬁc,
Waltham, MA) containing protease inhibitor cocktail (Sigma-Aldrich,
St. Louis, MO). After being clariﬁed by centrifugation at 15,000g for
15 min, cell lysates were mixed with Laemmli sample buﬀer (4X) and
heated at 95 °C for 6 min or 37 °C for 30 min. Proteins were separated
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred onto a nitrocellulose membrane. After overnight
blocking with 5% skim milk at 4 °C, the membrane was incubated with
the primary antibody at an appropriate dilution at room temperature
for 1 h. The membrane was washed three times with PBS containing
0.05% TWEEN 20 (PBST), and then incubated with the secondary an-
tibody, IRDye® 800CW Goat anti-Mouse IgG (H + L) or/and IRDye®
680RD Goat anti- Rabbit IgG (H + L) (LI-COR Biosciences, Lincoln, NE)
at an appropriate dilution for 1 h at room temperature. After ex-
tensively washing with PBST, the target proteins were visualized using
a digital image system (Odyssey infrared imaging system; LI-COR
Biosciences, Lincoln, NE).
4.7. Recovery of recombinant viruses from infectious cDNA clones
The recombinant viruses were launched by transfecting BHK-21
cells as described previously (Li et al., 2013). Brieﬂy, BHK-21 cells
(70–80% conﬂuency) were transfected with 2 μg of the type 2 PRRSV
full-length cDNA clone of pCMV-SD95-21 or the mutated full-length
cDNA clones (pCMV-SD95-21-KO1 and pCMV-SD95-21-KO2) using
FuGENE HD reagent (Promega, Madison, WI). At 48 h post transfection,
cell culture supernatant was harvested and passaged onto MARC-145
cells. The viability of recombinant viruses was conﬁrmed by indirect
immunoﬂuorescence assay using mAb SDOW17. The recombinant
viruses were serially passaged on MARC-145 cells, and the passage 4
viruses were used for further analysis.
4.8. In vitro growth characterization of recombinant viruses in cell culture
Growth kinetics of the recombinant and parental viruses were ex-
amined by infecting MARC-145 cells at an MOI of 0.01. Infected cells
were collected at 0, 12, 24, 36, 48, 60, 72 h post-infection (hpi). Viral
titers were determined by microtitration assay on MARC-145 cells and
calculated as TCID50/mL according to the Reed and Muench method
(Reed and Muench, 1938).
4.9. nCounter mRNA proﬁling for detecting immune gene expression
MARC-145 cells were infected with WT PRRSV SD95-21, vKO1, or
vKO2 at an MOI of 1.0. At 12 hpi, cells were harvested and subjected to
total RNA extraction using SV Total RNA Isolation kit (Promega,
Madison, WI) following the manufacturer's instructions. Total RNA
(100 ng/sample) was used in cellular gene expression proﬁling. The
expression levels of 579 immunological genes were evaluated by the
nCounter assay with nCounter® Human Immunology v2 kit according to
the manufacturer's instruction (NanoString Technologies, Seatle, WA),
and 15 housekeeping genes were included for data normalization.
Brieﬂy, hybridization reactions were prepared with 5 μl diluted sample
RNA according to the manufacturer's instruction. After 18 h of hy-
bridization at 65 °C, the excess probes were removed and the hy-
bridized probe/target complexes were immobilized in an nCounter
cartridge using the nCounter Prep Station (Nanostring Technologies,
Seatle, WA). Sample Cartridges were placed in a Digital Analyzer for
data collection. The gene expression data were analyzed with nSolver
2.6 according to the manufacturer's instruction (NanoString
Technologies, Seatle, WA). Using gene expression in uninfected control
cells as a reference, genes in virus-infected cells with a p-value lower
than 0.05 and a fold change greater than 2 were deﬁned as diﬀeren-
tially expressed genes (DEGs).
4.10. KEGG pathway enrichment and protein-protein interaction network
analysis
The Database for Annotation, Visualization and Integrated
Discovery (DAVID) (Huang et al., 2009a, 2009b) was used to perform
KEGG functional enrichment analysis of biological pathways that sig-
niﬁcantly enriched with DEGs from individual viral infection. A
minimum count of 4 genes was used as the cut-oﬀ for determination of
enriched biological pathways, and the p-values adjusted by Benjamini-
Hochberg correction less than 0.05 were deﬁned as signiﬁcant enrich-
ment. Protein-protein interaction (PPI) networks were constructed
using Search Tool for the Retrieval of Interacting Genes/Proteins
(STRING v10.0, http://string-db.org) (Szklarczyk et al., 2015) using
DEG list from each viral infection. PPI conﬁdence networks were gen-
erated using the conﬁdence view option at a medium conﬁdence of
0.400.
4.11. Quantitative RT-PCR for immune gene detection
To verify the results of nCounter gene expression proﬁling, the ex-
pression levels of selected genes were further evaluated by quantitative
RT-PCR using the total RNA of the same sample for nCounter analysis.
Brieﬂy, cDNA was generated with 1 μg total RNA using SuperScript
VILO cDNA Synthesis Kit (Life Technologies, Carlsbad, CA). According
to the manufacturer's instruction, PCR reaction was formulated with
10 μl TaqMan Fast Advanced Master Mix (Applied Biosystems, Foster
City, CA), 1 μl cDNA, and 1 μl of predesigned primer/probe sets
(Applied Biosystems, Foster City, CA) for IFN-α, IFN-β, IRF-7, IL-28B,
IFIT1, IFITM1 and TBP (TATA Box Binding Protein). Reactions were
completed on CFX96 Real-Time PCR system (Bio-Rad) under the fol-
lowing conditions: 2 min of 50 °C for UNG activation, 20 s of 95 °C for
polymerase activation, 40 ampliﬁcation cycles of 30 s of 95 °C and 30 s
of 60 °C. The mRNA expression levels of IFN-α, IFN-β, IRF-7, IL-28B,
IFIT1 and IFITM1 were normalized to the endogenous TBP mRNA level.
To assess the ability of mutant viruses to stimulate innate immune
responses in virus-infected swine macrophages, PAMs were infected
with WT virus, vKO1 or vKO2 at an MOI of 1.0. At 12 hpi, cells were
harvested in TRIzol LS (Life Technologies, Carlsbad, CA) and total
cellular RNA was extracted according to the manufacturer's instruction.
The mRNA expression levels of IFN-α, IFN-β, IRF-7, IL-28B, IFIT1,
IFITM1 were quantiﬁed by quantitative RT-PCR using predesigned
probe/primer sets (Applied Biosystems, Foster City, CA) and normal-
ized to the housekeeping gene GAPDH mRNA.
4.12. Pig groups, sample collection and preparation
A total of thirty-six 4-week-old PRRSV-naive pigs were obtained
from a certiﬁed PRRSV-negative herd. They were divided randomly
into 4 groups (n=9) and housed separately in an animal isolation fa-
cility. After a four-day acclimation period, group 1 pigs were mock-
infected with cell culture medium, while pigs from group 2–4 were
inoculated with WT virus (group 2), vKO1 (group 3) or vKO2 (group 4).
Pigs were immunized through both intranasal (IN) and intramuscular
(IM) routes with 1 mL (1×106 TCID50) of the virus suspension in MEM
to each nostril and to each side of the neck. Pigs were observed daily
and serum samples were collected at 0, 1, 2, 6, 21, 28 DPI. Three pigs
from each group were sequentially euthanized at 6, 21, and 28 DPI.
During necropsy, whole blood was collected from each pig for
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preparation of peripheral blood mononuclear cells (PBMCs), and gross
lung lesions were evaluated using the method described previously
(Halbur et al., 1995). The pig experiment was performed according to
the protocol approved by the Institutional Animal Care and Use Com-
mittee (IACUC) of The Ohio State University, Ohio.
4.13. Quantiﬁcation of viral load
For the detection of viral RNA and quantiﬁcation of viral load,
serum samples were examined using a quantitative RT-PCR method as
described previously (Li et al., 2016).
4.14. Analysis of swine cytokine response
Serum samples collected at 0, 1, 2 and 6 DPI were used to evaluate
IFN-α production using ProcartaPlex Porcine IFN alpha Simplex kit
(eBioscience, San Diego, CA) per manufacturer's instructions.
4.15. Pig NK cell cytotoxic assay
Pig natural killer (NK) cell-mediated cytotoxicity was determined
with an immunoﬂuorescence-based assay using a modiﬁed method
described previously (Lecoeur et al., 2001). A 7-aminoactinomycin D
(7-AAD)/carboxyﬂuorescein succinimidyl ester (CFSE) cell-mediated
cytotoxicity assay kit (Cayman Chemical, Ann Arbor, MI) was used.
PBMCs were used as the source of NK cells (eﬀectors), and K562
(human myeloblastoid cell line) cells were used as target cells.
4.16. Flow cytometry analysis
To measure the frequencies of virus-speciﬁc lymphocyte population,
PBMCs isolated at 6, 21 and 28 DPI were restimulated with WT virus at
an MOI of 0.1. At 72-h post stimulation, cells were subjected to ﬂow
cytometry analysis to determine the frequency of T-helper cells
(CD3+CD4+CD8α-) and cytotoxic T cells (CD3+CD4-CD8αβ+) using
the modiﬁed method described previously (Binjawadagi et al., 2014;
Dhakal et al., 2017). Brieﬂy, PBMCs plated in a 96 well-plate were
surface-labeled with swine lymphocyte speciﬁc ﬂuorochrome- or
biotin-conjugated monoclonal antibody, and then stained with ﬂuor-
ochrome-labeled anti-mouse isotype speciﬁc antibody or streptavidin.
Antibodies used in the ﬂow cytometry were anti-porcine CD3, CD4α
and CD8α (Southernbiotech, AL) and CD8β (BD Biosciences, CA). Im-
munostained cells were acquired using the FACS Aria II (BD Bios-
ciences) ﬂow cytometer and analyzed using FlowJo (Tree Star, Ashland,
OR, USA) software. All speciﬁc cell population frequencies were pre-
sented as the percentage of CD3+ cells in PBMCs.
4.17. Statistical analysis
Statistical analysis was performed using GraphPad InStat version
5.0 (GraphPad Software). Comparisons among treatment groups were
performed using one-way analysis of variance (ANOVA) followed by
Tukey's post hoc test to determine the statistical signiﬁcance. A p-value
below 0.05 was considered to indicate a statistically signiﬁcant diﬀer-
ence between treatment groups. Due to co-housing of pigs infected with
the same virus (WT or a mutant virus), co-housed pigs are not strictly
speaking completely independent samples, thus p-values in Figs. 6–8
should be treated with caution.
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